Updosing of secukinumab to every 2 weeks results in superior efficacy in patients with severe psoriasis weighing 90 kg or more: a real-world prospective observational study

Niamh McGuire,Shahd Elamin,Pamela Gough,Nicola Cooke,Conor McGrath,Kevin McKenna,Donal O'Kane

CLINICAL AND EXPERIMENTAL DERMATOLOGY（2023）

引用 0|浏览0

暂无评分

摘要

This is the first real-world prospective observational study demonstrating the superior efficacy of secukinumab dosing every 2 weeks in patients with severe psoriasis whose weight is > 90 kg.

查看译文

关键词

severe psoriasis,secukinumab,superior efficacy,real-world

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要